Диссертация (1174268), страница 20
Текст из файла (страница 20)
- № 7. – Р. 1637-45.89. Vallejo, E. Myocardial perfusion SPECT imaging in patients with myocardialbridging / E. Vallejo, M. Morales, I. Sanchez [et al.] // J Nucl Cardiol. – 2005. – Vol.12.- № 3. - Р. 318-2390. Gawor, R. Myocardial perfusion GSPECT imaging in patients with myocardialbridging / R. Gawor, J. Kuśmierek, A. Płachcińska [et al.] // Journal of NuclearCardiology. - 2011.
– Vol. 18 - № 6. – Р. 1059–65.91. Yoshino, S. Fractional flow reserve with dobutamine challenge and coronarymicrovascular endothelial dysfunction in symptomatic myocardial bridging / S.Yoshino, A. Cassar, Y. Matsuo [et al.] // Circulation Journal. – 2014. – Vol. 78. - № 3. –Р. 685–92.92. Basso, C. Myocardial bridging, a frequent component of the hypertrophiccardiomyopathy phenotype, lacks systematic association with sudden cardiac death / C.Basso, G. Thiene, S. Mackey-Bojack [et al.] // Eur Heart J.
– 2009. – Vol. 30. – №13. P. 1627-3412593. Sorajja, P. Myocardial bridging in adult patients with hypertrophic cardiomyopathy/ P. Sorajja, S.R. Ommen, R.A. Nishimura [et al.] // J Am Coll Cardiol. – 2003. – Vol.42. - № 5. -P. 889-9494. Mohiddin, S.A. Myocardial bridging does not predict sudden death in children withhypertrophic cardiomyopathy but is associated with more severe cardiac disease / S.A.Mohiddin, D.
Begley, J. Shih. [et al.] // J Am Coll Cardiol. – 2000. – Vol.36. - № 7. - Р.2270–78.95. Tian, T. Myocardial bridging as a common phenotype of hypertrophiccardiomyopathy has no effect on prognosis / T. Tian, Y.L. Wang, J.Z. Wang [et al.] /Am J Med Sci. – 2014. – Vol. 347. - № 6. – P. 429-33.96. Kaufmann, P. Coronary artery dimensions in primary and secondary left ventricularhypertrophy [et al.] / P.
Kaufmann , G. Vassalli , S. Lupi-Wagner // J Am Coll Cardiol.– 1996. – Vol. 28. - № 3. - Р.745-50.97. Sellers, S.L. Hypertrophic Cardiomyopathy (HCM): New insights into Coronaryartery remodelling and ischemia from FFRCT / S.L. Sellers., T.A. Fonte , R. Grover [etal] // J Cardiovasc Comput Tomogr. - 2018. – Vol. 12. - № 6. - P.467-47198.
Mahadevappa, M. Normal Proximal Coronary Artery Diameters in Adults fromIndia as Assessed by Computed Tomography Angiography / M. Mahadevappa, M.Hegde, R. Math // J Clin Diagn Res. – 2016. – Vol. 10. - № 5. – Р. TC10-399. Dodge, J.T. Jr. Lumen diameter of normal human coronary arteries. Influence ofage, sex, anatomic variation, and left ventricular hypertrophy or dilation / J.T. Jr.Dodge, B.G. Brown, E.L. Bolson [et al] / Circulation. – 1992. – Vol. 86. - №1. – Р.232–46.100. Daralammouri, Y. Hypertrophic cardiomyopathy mimicking acute anteriormyocardial infarction associated with sudden cardiac death / Y. Daralammouri, M.
ElGarhy, K. Same [et al] // Case Rep Med. – 2012. – Vol. 2012. – P. 1-4. – ID 236154.101. Olearczyk, B. Apical hypertrophic cardiomyopathy mimicking acute coronarysyndrome: a case report and review of the literature / B. Olearczyk, N. Gollol-Raju, D.J.Menzies // Angiology. – 2008. - Vol. 59. - № 5. – Р. 629-31.126102. Parr, C.J.
Apical hypertrophic cardiomyopathy treated as ST-elevation myocardialinfarction / C.J. Parr, R. Sharma , P.J. Garber // CJEM. – 2018. – Vol. 20. - № S2. – Р.S51-S55.103. Peters, S. A case of apical hypertrophic cardiomyopathy presenting as acutecoronary syndrome // Peters SInt J Cardiol. – 2016. Vol. 15. - № 207. – Р.
142.104. Duygu, H. Apical hypertrophic cardiomyopathy might lead to misdiagnosis ofischaemic heart disease / H. Duygu, M. Zoghi, S. Nalbantgil [et al] // Int J CardiovascImaging. - 2008. – Vol. 24. - № 7. – Р. 675-81105. Ushikoshi, H. An autopsy report of acute myocardial infarction with hypertrophicobstructive cardiomyopathy-like heart / H. Ushikoshi, H. Okada, K. Morishita [et al] //Cardiovasc Pathol.
- 2015. – Vol. 24 - № 6. - P.405-7106. Tascon, P. The therapeutic focus in severe hypertrophic obstructivecardiomyopathy with muitivessel coronary disease / P. Tascon, G. Trevilla, M.Gutierres [et al.] // Rev Esp Cardiol. – 1999. – Vol. 52. - № 5. – Р. 343–347.107. Elliott P.M. Chest pain during daily life in patients with hypertrophiccardiomyopathy: an ambulatory electrocardiographic study / P.M .Elliott, J.C. Kaski,K. Prasad [et al.] // Eur Heart J. - 1996. - Vol. 17. -№ 7. - P. 1056–64.108. Gibbons, R.J. ACC/AHA 2002 guideline update for exercise testing: summaryarticle. A report of the American College of Cardiology/American Heart AssociationTask Force on Practice Guidelines (Committee to Update the 1997 Exercise TestingGuidelines) // R.J.
Gibbons, G.J. Balady, J.T. Bricker // J Am Coll Cardiol. - 2002. –Vol. 40. - № 8. – Р. 1531-40.109. Morise, A.P. Exercise Testing in Nonatherosclerotic Heart Disease HypertrophicCardiomyopathy, Valvular Heart Disease, and Arrhythmias / A.P. Morise //Circulation. – 2011. – Vol. 123. - № 2. – P. 216-25.110. Cheng, T.O. Exercise testing in hypertrophic cardiomyopathy / T.O. Cheng // IntJ Cardiol. - 2008.
– Vol.123 – №3. - Р. 219–200.127111. Olivotto, I. Clinical utility and safety of exercise testing in patients withhypertrophic cardiomyopathy / I. Olivotto, A. Montereggi, F. Mazzuoli [et al.] // G ItalCardiol. – 1999. – Vol. 29. - № 1. – Р. 11-9.112. Hess, O.M. Risk stratification in hypertrophic cardiomyopathy. Fact or Fiction? /O.M. Hess // J. Am. Coll. Cardiol. - 2003. – Vol. 42.
- № 5. - P. 880-881.113. Lele, S.S. Exercise Capacity in Hypertrophic Cardiomyopathy. Role of StrokeVolume Limitation, Heart Rate, and Diastolic Filling Characteristics // S. S. Lele, H.L.Thomson, H. Seo et al. // Circulation. - 1995. – Vol. 92. - № 10. – Р. 2886-2894.114. McKenna, W.J. Hypertrophic cardiomyopathy: management, risk stratification,and prevention of sudden death / W. J.
McKenna, E.R. Behr // Heart. – 2002. – Vol. 87.- № 2. – Р. 169-176.115. Argulian E., Chaudhry F.A. Stress testing in patients with hypertrophiccardiomyopathy // Prog Cardiovasc Dis. – 2012. - Vol. 54. - № 6. – Р. 477-82.116. Drinko J.K. Safety of stress testing in patients with hypertrophic cardiomyopathy /J.K. Drinko, P.J. Nash, H.M. Lever [et al.] // Am J Cardiol. – 2004.
– Vol. 93. - № 11. –Р. 1443-4.117. Marcadet, D.M. French Society of Cardiology guidelines on exercise tests (part 2):Indications for exercise tests in cardiac diseases / D.M. Marcadet, B. Pavy, G. Bosser[et al.] // Arch Cardiovasc Dis. - 2019. – Vol. 112. - № 1. Р. 56-66.118. Rowin, E.J. Role of Exercise Testing in Hypertrophic Cardiomyopathy /E.J. Rowin, B.J. Maron, I. Olivotto [et al.] // JACC Cardiovasc Imaging. – 2017.
- Vol.10. - № 11. – Р.1374-1386.119. Cantor, A. The value of changes in QRS width and in ST-T segment duringexercise test in hypertrophic cardiomyopathy for identification of associated coronaryartery disease / A. Cantor, C. Yosefy, M. Potekhin [et al.] // Int J Cardiol. – 2006. – Vol.112. - № 1. – Р. 99–104.120. Tower-Rader, A.
A Comprehensive Review of Stress Testing in HypertrophicCardiomyopathy: Assessment of Functional Capacity, Identification of Prognostic128Indicators, and Detection of Coronary Artery Disease / A. Tower-Rader, J. Betancor,H.M. Lever [et al.] // J Am Soc Echocardiogr. – 2017. – Vol. 30. -№ 9. – Р. 829-844.121. Ogata, Y. Relationship of exercise or pacing induced ST segment depression andmyocardiallactate metabolism in patients with hypertrophic cardiomyopathy / Y. Ogata,K. Hiyamuta, M. Terasawa / Heart J.
- 1986. - Vol. 27.- №2.- P. 145-58.122. Miyai, N. Exercise-induced ST-segment depression and myocardial ischemia inpatients with hypertrophic cardiomyopathy: myocardial scintigraphic study / N. Miyai,T Kawasaki., T Taniguchi [et al.] // J Cardiol. – 2005. – Vol. 46. - № 4. – P.141-7.123. Kawasaki, T. Resting ST-segment depression predicts exercise-inducedsubendocardial ischemia in patients with hypertrophic cardiomyopathy / T. Kawasaki,A. Azuma, T. Kuribayashi [et al.] // Int J Cardiol.
– 2006. – Vol. 107. - № 2. – Р. 267–274.124. Picano, E. Stress echo 2020: the international stress echo study in ischemic andnon-ischemic heart disease / E. Picano , Q. Ciampi, R. Citro [et al.] // CardiovascUltrasound. - 2017. – Vol. 15. - № 3. – Р. 1-21.125. Ciampi, Q. Prognostic role of stress echocardiography in hypertrophiccardiomyopathy: The International Stress Echo Registry / Q. Ciampi , I. Olivotto , C.Gardini [et al.] // Int J Cardiol. – 2016.
– Vol. 219. - P. 331-8.126. Suzuki, K. Exercise stress echocardiography in hypertrophic cardiomyopathy / K.Suzuki, Y.J. Akashi // J Echocardiogr. - 2017. – Vol. 15. - № 3. Р. 110-117.127. Шапошник, И.И. Гипертрофическая кардиомиопатия / И.И. Шапошник И.И.,Д.В. Богданов. - М: Медпрактика-М, 2008. - 128 с.128. Синицын, В.Е.Возможности магнитно-резонансной томографиии вдиагностике кардиомиопатии / В.Е. Синицын, Е.А. Мершина, О.М.
Ларина //Клиническая и экспериментальная хирургия. Журнал имени академика Б.В.Петровского. - 2014. - № 1. - С. 54-63.129. Синицын, В.Е. Магнитно-резонансная томография сердца с отсроченнымконтрастированием в оценке очаговых изменений в миокарда левого желудочка у129больных с гипертрофической кардиомиопатией / В.Е. Синицын, О.В. Стукалова,О.В.Ларина [и др.] // Кардиологический вестник.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
